Other

Chiba University

Otsuka Pharmaceutical Company, Limited

Meiji Seika Kaisha, Ltd.

Iyo, Masaomi

Masaomi Iyo

Kenji Hashimoto

Takao Ueda

Isamu Yomoda

Kaori Koike

Shinichiro Nagatsuka

Masaru Nishiura

Hiroki Namba

Nobuo Ikota

Keizo Takatoku

Toshiaki Irie

Kiyoshi Fukushi

Yohko Maeda

Hajime Sasaki

Eiji Shimizu

Toshiya Inada

Hiroki Koizumi

Michiko Nakazato

Yoshie Kitao

A medicinal preparation for preventing and/or treating psychoneurotic diseases such as integration dysfunction and Alzheimer's disease which contains tropisetron or its pharmaceutically acceptable salt as the active ingredient.

Remedy for psychoneurotic diseases

The invention relates to a medicament for preventing and/or treating schizophrenia which comprises as an active ingredient cilostazol or a pharmaceutically acceptable salt thereof.

Medicament for treating schizophrenia comprising cilostazol

The present invention provides a diagnostic agent for eating disorders comprising as an active ingredient an antibody against brain-derived neurotrophic factor, and a method for detecting eating disorders comprising measuring of the concentration of a brain-derived neurotrophic factor in blood. Particularly, the eating disorders can easily be diagnosed by measuring the concentration of a brain-derived neurotrophic factor in blood of the patients with an antibody against brain-derived neurotrophic factor and a labeled antibody against brain-derived neurotrophic factor.

Diagnostic and examination method for eating disorder

Reagents for the determination of cerebral regional acetylcholinesterase activity

The present invention relates to N-alkylpiperidine derivatives represented by general formula (1) or (2);

Reagents for assaying central local acetylcholinesterase activity

Method for therapeutically treating tardive dyskinesia and uses thereof

Growing community of inventors

Chiba, Japan

Masaomi Iyo